Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance - Lin, Xixi; Jia, Yongliang; Dong, Xinwei; Shen, Jian; Jin, Yachao; Li, Yanyou; Wang, Fang; Anenberg, Eitan; Zhou, Jiancang; Zhu, Jianping; Chen, Xiaoping; Xie, Qiangmin; et al. (Frontiers in Pharmacology, 2022)